Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy

Area of Science:

• Oncology
• Cancer Biology
• Immunotherapy

Background:

• Melanoma dedifferentiation is often linked to therapy resistance.
• Cancer cells may revert to a primitive phenotype.

Purpose of the Study:

• To investigate the role of melanoma dedifferentiation in response to anti-programmed cell death 1 (anti-PD-1) therapy.
• To challenge the view of dedifferentiation as solely an adverse phenotype.

Main Methods:

• Analysis of patient tumor biopsies responding to anti-PD-1 therapy.
• In vitro modeling of melanoma cell lines exposed to interferon-gamma (IFN-γ).
• Assessment of global chromatin landscape changes and marker expression.

Main Results:

• Patient tumors responding to anti-PD-1 therapy showed decreased melanocytic and increased neural crest markers.
• In vitro, continuous IFN-γ exposure induced neural crest dedifferentiation in melanoma cells.
• Dedifferentiation involved global chromatin changes and hyperaccessible chromatin regions.
• The IFN-γ-induced dedifferentiation signature correlated with improved patient outcomes.

Conclusions:

• Treatment-induced melanoma dedifferentiation, characterized by neural crest markers, is associated with positive responses to anti-PD-1 immunotherapy.
• This finding challenges the established notion that neural crest dedifferentiation is exclusively a detrimental process in cancer.